Skip to main content
SpringerLink
Log in

Cardiac Tumors

  • Chapter
  • First Online:
FDG-PET/CT and PET/MR in Cardiovascular Diseases

  • 297 Accesses

Abstract

Although relatively rare, neoplastic cardiac lesions are regularly encountered on PET imaging. In the current chapter, we review the types of neoplastic lesions, both benign and malignant, which can be seen in the heart. We also discuss the pathways of spread by which secondary tumors can reach the heart. Finally, we review evidence behind the use of FDG-PET/CT and FDG-PET/MR for the evaluation of cardiac lesions.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Butany J, Nair V, Naseemuddin A, Nair GM, Catton C, Yau T. Cardiac tumours: diagnosis and management. Lancet Oncol. 2005;6(4):219–28.

    Article  PubMed  Google Scholar 

  2. Haskell RJ, French WJ. Cardiac tamponade as the initial presentation of malignancy. Chest. 1985;88(1):70–3.

    Article  CAS  PubMed  Google Scholar 

  3. Tamura A, Matsubara O, Yoshimura N, Kasuga T, Akagawa S, Aoki N. Cardiac metastasis of lung cancer. A study of metastatic pathways and clinical manifestations. Cancer. 1992;70(2):437–42.

    Article  CAS  PubMed  Google Scholar 

  4. Nakamura A, Suchi T, Mizuno Y. The effect of malignant neoplasms on the heart. A study on the electrocardiographic abnormalities and the anatomical findings in cases with and without cardiac involvement. Jpn Circ J. 1975;39(5):531–42.

    Article  CAS  PubMed  Google Scholar 

  5. Yusuf SW, Bathina JD, Qureshi S, Kaynak HE, Banchs J, Trent JC, Ravi V, Daher IN, Swafford J. Cardiac tumors in a tertiary care cancer hospital: clinical features, echocardiographic findings, treatment and outcomes. Heart Int. 2012;7(1):e4. https://doi.org/10.4081/hi.2012.e4.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Cates CU, Virmani R, Vaughn WK, Robertson RM. Electrocardiographic markers of cardiac metastasis. Am Heart J. 1986;112(6):1297–303.

    Article  CAS  PubMed  Google Scholar 

  7. Virmani R, Khedekar RR, Robinowitz M, McAllister HA. Tumor embolization in coronary artery causing myocardial infarction. Arch Pathol Lab Med. 1983;107(5):243–5.

    CAS  PubMed  Google Scholar 

  8. Ackermann DM, Hyma BA, Edwards WD. Malignant neoplastic emboli to the coronary arteries: report of two cases and review of the literature. Hum Pathol. 1987;18(9):955–9.

    Article  CAS  PubMed  Google Scholar 

  9. Franciosa JA, Lawrinson W. Coronary artery occlusion due to neoplasm. A rare cause of acute myocardial infarction. Arch Intern Med. 1971;128(5):797–801.

    Article  CAS  PubMed  Google Scholar 

  10. Frohlich ED, Shnider BI, Leonard JJ. Antemortem diagnosis of metastatic sarcoma to the heart: a case report. Am Heart J. 1959 Apr;57(4):623–9.

    Article  CAS  PubMed  Google Scholar 

  11. Borsaru A, Lau K, Solin P. Cardiac metastasis: a cause of recurrent pulmonary emboli. Br J Radiol. 2007;80(950):e50–3.

    Article  CAS  PubMed  Google Scholar 

  12. Nensa F, Tezgah E, Poeppel TD, Jensen CJ, Schelhorn J, Köhler J, et al. Integrated 18F-FDG PET/MR imaging in the assessment of cardiac masses: a pilot study. J Nucl Med. 2015;56(2):255–60.

    Article  PubMed  Google Scholar 

  13. Butany J, Leong SW, Carmichael K, Komeda M. A 30-year analysis of cardiac neoplasms at autopsy. Can J Cardiol. 2005;21(8):675–80.

    PubMed  Google Scholar 

  14. Travis WD. Pathology & genetics tumours of the lung, pleura, thymus and heart. In: World Health Organization classification of tumours; 2004.

    Google Scholar 

  15. Reynen K. Frequency of primary tumors of the heart. Am J Cardiol. 1996;77(1):107.

    Article  CAS  PubMed  Google Scholar 

  16. Oliveira GH, Al-Kindi SG, Hoimes C, Park SJ. Characteristics and survival of malignant cardiac tumors: a 40-year analysis of >500 patients. Circulation. 2015;132(25):2395–402.

    Article  PubMed  Google Scholar 

  17. Travis WD, Brambilla E, Burke AP, Marx A, Nicholson AG. Introduction to the 2015 World Health Organization classification of tumors of the lung, pleura, thymus, and heart. J Thorac Oncol. 2015;10(9):1240–2.

    Article  PubMed  Google Scholar 

  18. Rahouma M, Arisha MJ, Elmously A, El-Sayed Ahmed MM, Spadaccio C, Mehta K, et al. Cardiac tumors prevalence and mortality: a systematic review and meta-analysis. Int J Surg. 2020;76:178–89.

    Article  PubMed  Google Scholar 

  19. Waller BF, Grider L, Rohr TM, Mclaughlin T, Taliercio CP, Fetters J. Intracardiac thrombi: frequency, location, etiology, and complications: a morphologic review—part I. Clin Cardiol. 1995;18(8):477–9.

    Article  CAS  PubMed  Google Scholar 

  20. Chaudhuri KG, Revels JW, Yadwadkar KS, Johnson LS. Intense 18F-FDG uptake in an organizing right atrial thrombus mimicking malignancy. Radiol Case Rep. 2017;12(3):449–54.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Chen-Milhone CS, Chakravarthy Potu K, Mungee S. Cardiac Aspergilloma: a rare case of a cardiac mass involving the native tricuspid valve, right atrium, and right ventricle in an immunocompromised patient. Case Rep Cardiol. 2018;2018:6927436.

    PubMed  PubMed Central  Google Scholar 

  22. Mazokopakis EE, Syros PK, Starakis IK. Nonbacterial thrombotic endocarditis (marantic endocarditis) in cancer patients. Cardiovasc Hematol Disord Drug Targets. 2010;10(2):84–6.

    Article  CAS  PubMed  Google Scholar 

  23. Buteau JP, Morais J, Keu KV. 18F-FDG PET/CT uptake of a nonbacterial thrombotic endocarditis. J Nucl Cardiol. 2016;23(6):1501–3.

    Article  PubMed  Google Scholar 

  24. Reynolds C, Tazelaar HD, Edwards WD. Calcified amorphous tumor of the heart (cardiac CAT). Hum Pathol. 1997;28(5):601–6.

    Article  CAS  PubMed  Google Scholar 

  25. de Hemptinne Q, de Cannière D, Vandenbossche J-L, Unger P. Cardiac calcified amorphous tumor: a systematic review of the literature. IJC Heart Vasc. 2015;7:1–5.

    Article  Google Scholar 

  26. Prichard RW. Tumors of the heart: review of the subject and report of one hundred and fifty cases. Arch Pathol. 1951;51:98–128.

    CAS  Google Scholar 

  27. Burke AP, Virmani R. Cardiac myxoma: a clinicopathologic study. Am J Clin Pathol. 1993;100(6):671–80.

    Article  CAS  PubMed  Google Scholar 

  28. Reynen K. Cardiac myxomas. N Engl J Med. 1995;333(24):1610–7.

    Article  CAS  PubMed  Google Scholar 

  29. Sarjeant JM, Butany J, Cusimano RJ. Cancer of the heart. Am J Cardiovasc Drugs. 2003;3(6):407–21.

    Article  PubMed  Google Scholar 

  30. Pinede L, Duhaut P, Loire R. Clinical presentation of left atrial cardiac myxoma: a series of 112 consecutive cases. Medicine. 2001;80(3):159–72.

    Article  CAS  PubMed  Google Scholar 

  31. McAllister HA, Fenoglio JJ. Tumors of the cardiovascular system. Washington, DC: Armed Forces Institute of Pathology; 1978.

    Google Scholar 

  32. Grebenc ML, Rosado-de-Christenson ML, Green CE, Burke AP, Galvin JR. From the archives of the AFIP: cardiac myxoma: imaging features in 83 patients. Radiographics. 2002;22(3):673–89.

    Article  PubMed  Google Scholar 

  33. Gheysens O, Cornillie J, Voigt J-U, Bogaert J, Westhovens R. Left atrial myxoma on FDG-PET/CT. Clin Nucl Med. 2013;38(11):e421–2.

    Article  PubMed  Google Scholar 

  34. Okazaki Y, Yamada S, Kitada S, Matsunaga I, Nogami E, Watanabe T, et al. Significance of 18 F-FDG PET and immunohistochemical GLUT-1 expression for cardiac myxoma. Diagn Pathol. 2014;9(1):117.

    Article  PubMed  PubMed Central  Google Scholar 

  35. Billet S, Lavie-Badie Y, Hitzel A, Lairez O. What is the role of 18F-FDG uptake intensity in suspected atrial myxoma exploration? J Nucl Cardiol. 2018;25(5):1861–2.

    Article  PubMed  Google Scholar 

  36. Waller DA, Ettles DF, Saunders NR, Williams G. Recurrent cardiac myxoma: the surgical implications of two distinct groups of patients. Thorac Cardiovasc Surg. 1989;37(4):226–30.

    Article  CAS  PubMed  Google Scholar 

  37. McCarthy PM, Piehler JM, Schaff HV, Pluth JR, Orszulak TA, Vidaillet HJ, et al. The significance of multiple, recurrent, and “complex” cardiac myxomas. J Thorac Cardiovasc Surg. 1986;91(3):389–96.

    Article  CAS  PubMed  Google Scholar 

  38. Mariscalco G, Bruno VD, Borsani P, Dominici C, Sala A. Papillary fibroelastoma: insight to a primary cardiac valve tumor. J Card Surg. 2010;25(2):198–205.

    Article  PubMed  Google Scholar 

  39. Burke A, Jeudy J, Virmani R. Cardiac tumours: an update. Heart. 2008;94(1):117–23.

    Article  PubMed  Google Scholar 

  40. Motwani M, Kidambi A, Herzog BA, Uddin A, Greenwood JP, Plein S. MR imaging of cardiac tumors and masses: a review of methods and clinical applications. Radiology. 2013;268(1):26–43.

    Article  PubMed  Google Scholar 

  41. Freedom R, Lee K-J, MacDonald C, Taylor G. Selected aspects of cardiac tumors in infancy and childhood. Pediatr Cardiol. 2000;21(4):299–316.

    Article  CAS  PubMed  Google Scholar 

  42. Günther T, Schreiber C, Noebauer C, Eicken A, Lange R. Treatment strategies for pediatric patients with primary cardiac and pericardial tumors: a 30-year review. Pediatr Cardiol. 2008;29(6):1071–6.

    Article  PubMed  Google Scholar 

  43. Kocabaş A, Ekici F, Cetin II, Emir S, Demir HA, Arı ME, et al. Cardiac rhabdomyomas associated with tuberous sclerosis complex in 11 children: presentation to outcome. Pediatr Hematol Oncol. 2013;30(2):71–9.

    Article  PubMed  Google Scholar 

  44. Harding CO, Pagon RA. Incidence of tuberous sclerosis in patients with cardiac rhabdomyoma. Am J Med Genet. 1990;37(4):443–6.

    Article  CAS  PubMed  Google Scholar 

  45. Bosi G, Lintermans J, Pellegrino P, Svaluto-Moreolo G, Vliers A. The natural history of cardiac rhabdomyoma with and without tuberous sclerosis. Acta Paediatr. 1996;85(8):928–31.

    Article  CAS  PubMed  Google Scholar 

  46. Burke A, Tavora F. The 2015 WHO classification of tumors of the heart and pericardium. J Thorac Oncol. 2016;11(4):441–52.

    Article  PubMed  Google Scholar 

  47. Burke AP, Rosado-de-Christenson M, Templeton PA, Virmani R. Cardiac fibroma: clinicopathologic correlates and surgical treatment. J Thorac Cardiovasc Surg. 1994;108(5):862–70.

    Article  CAS  PubMed  Google Scholar 

  48. Coffin CM. Case 1 congenital cardiac fibroma associated with Gorlin syndrome. Pediatr Pathol. 1992;12(2):255–62.

    Article  CAS  PubMed  Google Scholar 

  49. Burke A, Johns JP, Virmani R. Hemangiomas of the heart. A clinicopathologic study of ten cases. Am J Cardiovasc Pathol. 1990;3(4):283–90.

    CAS  PubMed  Google Scholar 

  50. Mandak JS, Benoit CH, Starkey RH, Nassef LA Jr. Echocardiography in the evaluation of cardiac pheochromocytoma. Am Heart J. 1996;132(5):1063–6.

    Article  CAS  PubMed  Google Scholar 

  51. Huo JL, Choi JC, DeLuna A, Lee D, Fleischmann D, Berry GJ, et al. Cardiac paraganglioma: diagnostic and surgical challenges. J Card Surg. 2012;27(2):178–82.

    Article  PubMed  Google Scholar 

  52. Woodward PJ, Sohaey R, Kennedy A, Koeller KK. From the archives of the AFIP: a comprehensive review of fetal tumors with pathologic correlation. Radiographics. 2005;25(1):215–42.

    Article  PubMed  Google Scholar 

  53. Sklansky M, Greenberg M, Lucas V, Gruslin-Giroux A. Intrapericardial teratoma in a twin fetus: diagnosis and management. Obstet Gynecol. 1997;89(5):807–9.

    Article  CAS  PubMed  Google Scholar 

  54. Chen TW-W, Loong HH, Srikanthan A, Zer A, Barua R, Butany J, et al. Primary cardiac sarcomas: a multi-national retrospective review. Cancer Med. 2019;8(1):104–10.

    Article  PubMed  Google Scholar 

  55. Sparrow PJ, Kurian JB, Jones TR, Sivananthan MU. MR imaging of cardiac tumors. Radiographics. 2005;25(5):1255–76.

    Article  PubMed  Google Scholar 

  56. Burke AP, Cowan D, Virmani R. Primary sarcomas of the heart. Cancer. 1992;69(2):387–95.

    Article  CAS  PubMed  Google Scholar 

  57. Best AK, Dobson RL, Ahmad AR. Best cases from the AFIP. Radiographics. 2003;23(suppl_1):S141–5.

    Article  PubMed  Google Scholar 

  58. Neragi-Miandoab S, Kim J, Vlahakes GJ. Malignant tumours of the heart: a review of tumour type. Diag Ther Clin Oncol. 2007;19(10):748–56.

    Article  CAS  Google Scholar 

  59. Burke A. Primary malignant cardiac tumors. Semin Diagn Pathol. 2008;25(1):39–46.

    Article  PubMed  Google Scholar 

  60. Butany J, Yu W. Cardiac angiosarcoma: two cases and a review of the literature. Can J Cardiol. 2000;16(2):197–205.

    CAS  PubMed  Google Scholar 

  61. Jellis C, Doyle J, Sutherland T, Gutman J, Mac IA. Cardiac epithelioid leiomyosarcoma and the role of cardiac imaging in the differentiation of intracardiac masses. Clin Cardiol. 2010;33(6):E6–9.

    Article  PubMed  PubMed Central  Google Scholar 

  62. Wang J-G, Cui L, Jiang T, Li Y-J, Wei Z-M. Primary cardiac leiomyosarcoma: an analysis of clinical characteristics and outcome patterns. Asian Cardiovasc Thorac Ann. 2015;23(5):623–30.

    Article  PubMed  Google Scholar 

  63. Araoz PA, Eklund HE, Welch TJ, Breen JF. CT and MR imaging of primary cardiac malignancies. Radiographics. 1999;19(6):1421–34.

    Article  CAS  PubMed  Google Scholar 

  64. Gilkeson RC, Chiles C. MR evaluation of cardiac and pericardial malignancy. J Magn Reson Imaging. 2003;11(1):173–86.

    Google Scholar 

  65. Hwa J, Ward C, Nunn G, Cooper S, Lau K-C, Sholler G. Primary intraventricular cardiac tumors in children: contemporary diagnostic and management options. Pediatr Cardiol. 1994;15(5):233–7.

    Article  CAS  PubMed  Google Scholar 

  66. Simsek H, Sahin M, Gumrukcuoglu HA, Tuncer M, Gunes Y. Recurrence of primary cardiac rhabdomyosarcoma without methastasis two years after surgery. Eur J Gen Med. 2012;9(2):146–8.

    Google Scholar 

  67. Cresti A, Chiavarelli M, Glauber M, Tanganelli P, Scalese M, Cesareo F, et al. Incidence rate of primary cardiac tumors: a 14-year population study. J Cardiovasc Med. 2016;17(1):37–43.

    Article  Google Scholar 

  68. Hudzik B, Miszalski-Jamka K, Glowacki J, Lekston A, Gierlotka M, Zembala M, et al. Malignant tumors of the heart. Cancer Epidemiol. 2015;39(5):665–72.

    Article  PubMed  Google Scholar 

  69. Gruver AM, Huba MA, Dogan A, Hsi ED. Fibrin-associated large B-cell lymphoma: part of the Spectrum of cardiac lymphomas. Am J Surg Pathol. 2012;36(10):1527–37.

    Article  PubMed  Google Scholar 

  70. Travis WD, Brambilla E, Burke AP, Marx A, Nicholson AG. WHO classification of tumours of the lung, pleura, thymus and heart. 4th ed; 2015.

    Google Scholar 

  71. Petrich A, Cho SI, Billett H. Primary cardiac lymphoma: an analysis of presentation, treatment, and outcome patterns. Cancer. 2011;117(3):581–9.

    Article  PubMed  Google Scholar 

  72. Lam KY, Dickens P, Chan A. Tumors of the heart. A 20-year experience with a review of 12, 485 consecutive autopsies. Arch Pathol Lab Med. 1993;117(10):1027.

    CAS  PubMed  Google Scholar 

  73. Klatt EC, Heitz DR. Cardiac metastases. Cancer. 1990;65(6):1456–9.

    Article  CAS  PubMed  Google Scholar 

  74. Bussani R, De-Giorgio F, Abbate A, Silvestri F. Cardiac metastases. J Clin Pathol. 2007;60(1):27–34.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  75. Glancy DL, Roberts WC. The heart in malignant melanoma: a study of 70 autopsy cases. Am J Cardiol. 1968;21(4):555–71.

    Article  CAS  PubMed  Google Scholar 

  76. Burke A, Tavora F. Hematologic tumors of the heart and pericardium. In: Tumors of the heart and great vessels. Annapolis Junction, MD: American Registry of Pathology; 2015. p. 337–52.

    Google Scholar 

  77. Moore JA, DeRan BP, Minor R, Julie A, Fraker TD. Transesophageal echocardiographic evaluation of intracardiac lymphoma. Am Heart J. 1992;124(2):514–6.

    Article  CAS  PubMed  Google Scholar 

  78. Goldberg AD, Blankstein R, Padera RF. Tumors metastatic to the heart. Circulation. 2013;128(16):1790–4.

    Article  PubMed  Google Scholar 

  79. Kline IK. Cardiac lymphatic involvement by metastatic tumor. Cancer. 1972;29(3):799–808.

    Article  CAS  PubMed  Google Scholar 

  80. Onuigbo WIB. The spread of lung cancer to the heart, pericardium and great vessels. Jpn Heart J. 1974;15(3):234–8.

    Article  CAS  PubMed  Google Scholar 

  81. Rusch VW, Asamura H, Watanabe H, Giroux DJ, Rami-Porta R, Goldstraw P. The IASLC lung cancer staging project: a proposal for a new international lymph node map in the forthcoming seventh edition of the TNM classification for lung cancer. J Thorac Oncol. 2009;4(5):568–77.

    Article  PubMed  Google Scholar 

  82. Aagaard CO. Les vaisseaux lymphatiques du cœur chez l’homme et chez quelques mammifières: Illustré par 108 figures originales et 46 autres gravures tous comprises dans le texte. Levin & Munksgaard; French. 1924.

    Google Scholar 

  83. Patek PR. The morphology of the lymphactics of the mammalian heart. Am J Anat. 1939;64(2):203–49.

    Article  Google Scholar 

  84. Kline I. Lymphatic pathways in the heart. Arch Pathol. 1969;88(6):638–44.

    CAS  PubMed  Google Scholar 

  85. Feola M, Merklin R, Cho S, Brockman SK. The terminal pathway of the lymphatic system of the human heart. Ann Thorac Surg. 1977;24(6):531–6.

    Article  CAS  PubMed  Google Scholar 

  86. Riquet M, Le Pimpec BF, Souilamas R, Hidden G. Thoracic duct tributaries from intrathoracic organs. Ann Thorac Surg. 2002;73(3):892–8.

    Article  PubMed  Google Scholar 

  87. Eliskova M, Eliska O, Miller AJ. The lymphatic drainage of the parietal pericardium in man. Lymphology. 1995;28(4):208–17.

    CAS  PubMed  Google Scholar 

  88. Chareonthaitawee P, Beanlands RS, Chen W, Dorbala S, Miller EJ, Murthy VL, et al. Joint SNMMI–ASNC expert consensus document on the role of 18F-FDG PET/CT in cardiac sarcoid detection and therapy monitoring. J Nucl Med. 2017;58(8):1341–53.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  89. Soussan M, Brillet P-Y, Nunes H, Pop G, Ouvrier M-J, Naggara N, et al. Clinical value of a high-fat and low-carbohydrate diet before FDG-PET/CT for evaluation of patients with suspected cardiac sarcoidosis. J Nucl Cardiol. 2013;20(1):120–7.

    Article  PubMed  Google Scholar 

  90. Tang R, Wang JT-Y, Wang L, Le K, Huang Y, Hickey AJ, et al. Impact of patient preparation on the diagnostic performance of 18F-FDG PET in cardiac sarcoidosis: a systematic review and meta-analysis. Clin Nucl Med. 2016;41(7):e327–39.

    Article  PubMed  Google Scholar 

  91. Kassop D, Donovan MS, Cheezum MK, Nguyen BT, Gambill NB, Blankstein R, et al. Cardiac masses on cardiac CT: a review. Curr Cardiovasc Imaging Rep. 2014;7(8):9281.

    Article  PubMed  PubMed Central  Google Scholar 

  92. Rahbar K, Seifarth H, Schäfers M, Stegger L, Hoffmeier A, Spieker T, et al. Differentiation of malignant and benign cardiac tumors using 18F-FDG PET/CT. J Nucl Med. 2012;53(6):856–63.

    Article  CAS  PubMed  Google Scholar 

  93. Qin C, Shao F, Hu F, Song W, Song Y, Guo J, et al. 18F-FDG PET/CT in diagnostic and prognostic evaluation of patients with cardiac masses: a retrospective study. Eur J Nucl Med Mol Imaging. 2020;47(5):1083–93.

    Article  PubMed  Google Scholar 

  94. Meng J, Zhao H, Liu Y, Chen D, Hacker M, Wei Y, et al. Assessment of cardiac tumors by 18F-FDG PET/CT imaging: histological correlation and clinical outcomes. J Nucl Cardiol. 2020;28(5):2233–43. https://doi.org/10.1007/s12350-019-02022-1.

    Article  PubMed  Google Scholar 

  95. Shao D, Wang S-X, Liang C-H, Gao Q. Differentiation of malignant from benign heart and pericardial lesions using positron emission tomography and computed tomography. J Nucl Cardiol. 2011;18(4):668–77.

    Article  PubMed  Google Scholar 

  96. Kikuchi Y, Oyama-Manabe N, Manabe O, Naya M, Ito YM, Hatanaka KC, et al. Imaging characteristics of cardiac dominant diffuse large B-cell lymphoma demonstrated with MDCT and PET/CT. Eur J Nucl Med Mol Imaging. 2013;40(9):1337–44.

    Article  PubMed  Google Scholar 

  97. Liu E-T, Sun T-T, Dong H-J, Wang S-Y, Chen Z-R, Liu C, et al. Combined PET/CT with thoracic contrast-enhanced CT in assessment of primary cardiac tumors in adult patients. EJNMMI Res. 2020;10(1):1–13.

    Article  Google Scholar 

  98. Concetta D’AE, Pasquale P, Giovanni V, Alberto F, Luca B, Ilenia M, et al. Diagnostic accuracy of cardiac computed tomography and 18-F Fluorodeoxyglucose positron emission tomography in cardiac masses. JACC Cardiovasc Imaging. 2020;13(11):2400–11.

    Article  Google Scholar 

  99. Chan AT, Josef F, Rocio PJ, Jiwon K, Brouwer LR, John G, et al. Late gadolinium enhancement cardiac magnetic resonance tissue characterization for cancer-associated cardiac masses: metabolic and prognostic manifestations in relation to whole-body positron emission tomography. J Am Heart Assoc. 2019;8(10):e011709.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  100. Lemasle M, Badie YL, Cariou E, Fournier P, Porterie J, Rousseau H, et al. Contribution and performance of multimodal imaging in the diagnosis and management of cardiac masses. Int J Cardiovasc Imaging. 2020;36(5):971–81.

    Article  PubMed  Google Scholar 

  101. Zeitouni M, Calais J, Ghodbane W, Ou P, Sannier A, Bouleti C. A cardiac myxoma with intense metabolic activity. Can J Cardiol. 2018;34(1):92.e11–2.

    Article  Google Scholar 

  102. Masuda A, Manabe O, Oyama-Manabe N, Naya M, Obara M, Sakakibara M, et al. Cardiac fibroma with high 18F-FDG uptake mimicking malignant tumor. J Nucl Cardiol. 2017;24(1):323–4.

    Article  PubMed  Google Scholar 

  103. Jiang Y, Ma X, Tan Y, Lu Q, Wang Y. Hamartoma of mature cardiac myocytes mimicking malignancy on 18F-FDG PET/CT images. Clin Nucl Med. 2019;44(11):892–4.

    Article  PubMed  Google Scholar 

  104. Bilski M, Kamiński G, Dziuk M. Metabolic activity assessment of cardiac angiosarcoma by 18FDG PET-CT. Nucl Med Rev. 2012;15(1):83–4.

    Article  Google Scholar 

  105. Tan H, Jiang L, Gao Y, Zeng Z, Shi H. 18F-FDG PET/CT imaging in primary cardiac angiosarcoma: diagnosis and follow-up. Clin Nucl Med. 2013;38(12):1002–5.

    Article  PubMed  Google Scholar 

  106. Tokmak H, Demir N, Demirkol MO. Cardiac angiosarcoma: utility of [18F] fluorodeoxyglucose positron emission tomography–computed tomography in evaluation of residue, metastases, and treatment response. Vasc Health Risk Manag. 2014;10:399–401.

    Article  PubMed  PubMed Central  Google Scholar 

  107. Jain A, Simon S, Elangovan I. 18F-fluoro-deoxyglucose positron emission tomography-computed tomography in initial assessment and diagnosis of right atrial angiosarcoma with widespread visceral metastases: a rare case report and review of the literature. Indian J Nucl Med. 2015;30(1):51–4.

    Article  PubMed  PubMed Central  Google Scholar 

  108. Liu C, Zhao Y, Yin Z, Hu T, Ren J, Wei J, et al. Right atrial epithelioid angiosarcoma with multiple pulmonary metastasis confirmed by multimodality imaging-guided pulmonary biopsy: a case report and literature review. Medicine (Baltimore). 2018;97(30):e11588.

    Article  Google Scholar 

  109. Erdogan EB, Asa S, Aksoy SY, Ozhan M, Halac M. Appearance of recurrent cardiac myxofibrosarcoma on FDG PET/CT. Clin Nucl Med. 2014;39(6):559–60.

    Article  PubMed  Google Scholar 

  110. Taywade SK, Damle NA, Tripathi M, Arun Raj ST, Passah A, Malhi AS, et al. Unusual presentation of rare cardiac tumor: the role of F−18-Fluorodeoxyglucose positron emission tomography/computed tomography. Indian J Nucl Med. 2017;32(2):157–8.

    Article  PubMed  PubMed Central  Google Scholar 

  111. Cheng J, Ou X. Prominent bone marrow metastases without concurrent intra-chest metastasis in a case of cardiac Angiosarcoma. Clin Nucl Med. 2020;45(8):638–9.

    Article  PubMed  Google Scholar 

  112. Tripathy S, Tripathi M, Parida GK, Bal C, Shamim SA. Primary cardiac angiosarcoma with extensive visceral metastases: utility of 18F-Fluorodeoxyglucose positron emission tomography-computed tomography in response assessment to Sorafenib. Indian J Nucl Med. 2019;34(3):241–3.

    Article  PubMed  PubMed Central  Google Scholar 

  113. Okayama S, Dote Y, Takeda Y, Uemura S, Fujimoto S, Saito Y. Primary cardiac lymphoma: echocardiography and F-18-Fluorodeoxyglucose positron emission tomography in selection of a biopsy site. Echocardiography. 2013;30(1):E13–5.

    Article  PubMed  Google Scholar 

  114. Martineau P, Dilsizian V, Pelletier-Galarneau M. Incremental value of FDG-PET in the evaluation of cardiac masses. Curr Cardiol Rep. 2021;23(7):78.

    Article  PubMed  Google Scholar 

  115. Pollia JA, Gogol LJ. Some notes on malignancies of the heart. Am J Cancer. 1936;27(2):329–33.

    Article  Google Scholar 

  116. Scott RW, Garvin CF. Tumors of the heart and pericardium. Am Heart J. 1939;17(4):431–6.

    Article  Google Scholar 

  117. Walther H. Krebsmetastasen. Basel: Benno Schwabe; 1948. p. 311.

    Google Scholar 

  118. Young J, Goldman IR. Tumor metastasis to the heart. Circulation. 1954;9(2):220–9.

    Article  CAS  PubMed  Google Scholar 

  119. Gassman HS, Meadows R, Baker LA. Metastatic tumors of the heart. Am J Med. 1955;19(3):357–65.

    Article  CAS  PubMed  Google Scholar 

  120. Hanfling SM. Metastatic cancer to the heart. Circulation. 1960;22(3):474–83.

    Article  CAS  PubMed  Google Scholar 

  121. Berge T, Sievers J. Myocardial metastases. A pathological and electrocardiographic study. Br Heart J. 1968;30(3):383.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  122. Harrer W. Metastatic tumors involving the heart and pericardium. Pa Med. 1971;74:57–60.

    CAS  PubMed  Google Scholar 

  123. Lockwood WB, Broghamer WL. The changing prevalence of secondary cardiac neoplasms as related to cancer therapy. Cancer. 1980;45(10):2659–62.

    Article  CAS  PubMed  Google Scholar 

  124. Mukai K, Shinkai T, Tominaga K, Shimosato Y. The incidence of secondary tumors of the heart and pericardium: a 10-year study. Jpn J Clin Oncol. 1988;18(3):195–201.

    CAS  PubMed  Google Scholar 

  125. Karwinski B, Svendsen E. Trends in cardiac metastasis. APMIS. 1989;97(7–12):1018–24.

    Article  CAS  PubMed  Google Scholar 

  126. Manojlović S. Metastatic carcinomas involving the heart. Review of postmortem examination. Zentralbl Allg Pathol. 1990;136(7–8):657.

    PubMed  Google Scholar 

  127. Mac GW. Metastatic and invasive tumours involving the heart in a geriatric population: a necropsy study. Vichows Archiv A Pathol Anat Histol. 1991;419(3):183–9.

    Article  Google Scholar 

  128. Silvestri F, Bussani R, Pavletic N, Mannone T. Metastases of the heart and pericardium. G Ital Cardiol. 1997;27(12):1252.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. BC Cancer, Vancouver, BC, Canada

    Patrick Martineau

  2. Montreal Heart Institute, Montréal, QC, Canada

    Matthieu Pelletier-Galarneau

Authors
  1. Patrick Martineau
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Matthieu Pelletier-Galarneau
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Patrick Martineau .

Editor information

Editors and Affiliations

  1. Montreal Heart Institute, Montréal, QC, Canada

    Matthieu Pelletier-Galarneau

  2. BC Cancer Agency, Vancouver, BC, Canada

    Patrick Martineau

Rights and permissions

Reprints and permissions

Copyright information

© 2022 The Author(s), under exclusive license to Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Martineau, P., Pelletier-Galarneau, M. (2022). Cardiac Tumors. In: Pelletier-Galarneau, M., Martineau, P. (eds) FDG-PET/CT and PET/MR in Cardiovascular Diseases. Springer, Cham. https://doi.org/10.1007/978-3-031-09807-9_10

Download citation

  • DOI: https://doi.org/10.1007/978-3-031-09807-9_10

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-031-09806-2

  • Online ISBN: 978-3-031-09807-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation